Licensing and M&A
Anstalt für Zellforschung is currently expanding its product portfolio and partnership network with In-/Outlicensing and M&A and is constantly pursuing further expansion of its activities and pipeline. Your product dossiers may be of interest to us. If you have products available for licensing or acquisition, we may be interested.
For the markets in Switzerland we are interested for pharmaceutical products as well as medical products. Anstalt für Zellforschung is a Swissmedic as well as EU (Liechtenstein) registered pharma company and active on various international, EU and Swiss markets.